Call to stop SABA alone for mild asthma
'The blue inhaler is a killer,' says a leading European respiratory physician
3rd July 2019
By Clare Pain
The biggest change in asthma management for decades is underway, with expert groups warning against the use of short-acting beta2 agonists on their own.